117 results
8-K
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
of the selling holder(s), and any underwriting discounts and selling commissions) incident to the Company’s obligations under the Registration Rights Agreement
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
that such Investor is aware that there are substantial risks incident to the purchase and ownership of the Securities, including those set forth in the Company’s
8-K
EX-10.2
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
audit and cold comfort letters required by or incident to such performance); provided that in no event shall the Company be responsible for any
8-K
EX-3.6
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
of the Board of Directors and of the stockholders, and performing all other duties incident to the office of Secretary. The Secretary shall perform … such authority, is authorized to vote, represent, and exercise on behalf of the Corporation all rights incident to any and all shares or other equity interests
424B3
ORKA
Oruka Therapeutics Inc.
1 Aug 24
Prospectus supplement
4:10pm
security breach of other incident, whether real or perceived, could cause us to suffer reputational damage. Such incidents could result in costs
425
rtt2sxnchtngthr
3 Apr 24
Business combination disclosure
7:33am
8-K
EX-2.1
7v2uc2jykzomy
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am